BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Apr 18, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Pollinex Quattro Grass regulatory update

Allergy Therapeutics submitted an MAA to Swissmedic for its Pollinex Quattro Grass vaccine to treat grass pollen allergies. The subcutaneous vaccine is formulated with allergoids, tyrosine...

Read the full 107 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >